Quantum dots increase uptake of cancer drug

Researchers at the University at Buffalo (UB) have developed a technology using quantum dots that promises major implications for research and treatment of tuberculosis and other inflammatory lung diseases. They linked quantum dots with doxorubicin, an anti-cancer chemotherapy drug, to target lung cells known as alveolar macrophages (aMOs), which play a critical role in the pathogenesis of various inflammatory lung injuries.

A paper in Nanomedicine: Nanotechnology, Biology and Medicine describes the study, which tested the ability of linked quantum dot-doxorubicin (QD-DOX) to decrease lung inflammation by delivering QD-DOX or doxorubicin alone to rats and mice (and then assessing damage to the lung). Doxorubicin, a frequently used cancer drug, is known to cause a variety of damaging immune responses in cancer patients. Results showed that QD-DOX increased uptake of the drug compared with doxorubicin alone. The researchers also demonstrated that the drug is released from the QD-DOX formulation once it is delivered into the targeted cell and still retains its bioactivity.

Click to Enlarge
Compared with the image of lung tissue injected with doxorubicin alone (left), an image of lung tissue injected with linked quantum dot-doxorubicin (QD-DOX) (right) indicates indicates an increased uptake of the drug, as shown by the yellow dots. (Image courtesy University at Buffalo)

"Based on these results, we believe that linking quantum dots with therapeutic drugs may have tremendous potential...compared to other nanoparticle formulations, and should be further developed for lung pharmacotherapy applications," says Krishnan V. Chakravarthy, lead author on the paper.

More BioOptics World Current Issue Articles
More BioOptics World Archives Issue Articles

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

Merz acquires laser tattoo removal device maker ON Light Sciences

Merz North America has acquired ON Light Sciences, which develops technologies to enhance laser-based dermatology procedures.

Shortwave-infrared device could improve ear infection diagnosis

An otoscope-like device that could improve ear infection diagnosis uses shortwave-infrared light instead of visible light.

Laser therapy extracts rare tumor that grew human hair, skin in boy's skull

About four years ago, a tumor comprised of human skin, hair, bone and cartilage was fast-growing inside a Ramsey, MN, 10-year-old youth's brain.

Low-level laser therapy could speed muscle recovery at Rio 2016 Olympics

The gold medal-winning women’s U.S. Gymnastics team is reportedly experimenting with infrared light therapy to alleviate pain and reduce swelling in its athletes. (Update: A spokesperson for ...

Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...



Twitter- BioOptics World